S 4633
117th Congress
Senate
Health
Drug therapy
Medicaid
Mental health
Prescription drugs
State and local government operations
A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
Introduced: July 27, 2022
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 27, 2022
Read twice and referred to the Committee on Finance.
Jul 27, 2022
Introduced in Senate
Plain-English summary
This bill requires the Centers for Medicare & Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1
Cosponsors
1